Japanese encephalitis virus antigens — Drug Target

All drugs that target Japanese encephalitis virus antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Inactivated viral vaccine

Phase 3 pipeline (1)

• Japanese Encephalitis purified inactivated vaccine · Valneva Austria GmbH · Inactivated viral vaccine · Infectious Disease / Immunology
  This inactivated vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.